Are Biotechs Now Overvalued? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Are Biotechs Now Overvalued?

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: Jim Haynes who wrote ()	3/3/2000 4:48:00 PM
From: Mike McFarland	of 14

<Is the biotech sector as a whole undervalued, fairly valued or overvalued> Relative to the dot coms--undervalued. So if biotech is the new dot com sector, then biotech as a group will keep running. Relative to performance over the last decade, maybe overbought but fairly valued. You often hear that a person should own the leaders in a hot sector--so a person thinks of names like Celera, Immunex, and Genentech. And these stocks may perform as, say, Lucent and Cisco have. But in my opinion, you can still get the best bang for the buck by sifting through the wreckage left from the '90s. Look at three of my own biotech picks--small biotechs from the neurobiological subsector. quote.yahoo.com If I have run the scientific snif test filter correctly (which amounts to reading the entire SI thread, closing ones eyes, and using the Galactic Force <g>) AND the shareprice history gives us read on the recent undervaluation--plus the rate of recovery of the shareprice (uh, momentum I guess) then these three might do well for me. Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext